Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P Futures
5,896.00
-0.25(-0.00%)
Dow Futures
43,155.00
-22.00(-0.05%)
Nasdaq Futures
20,516.75
-2.75(-0.01%)
Russell 2000 Futures
2,252.90
-2.60(-0.12%)
Crude Oil
70.54
-0.02(-0.03%)
Gold
2,735.50
-3.40(-0.12%)

Adverum Biotechnologies, Inc. (ADVM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

8.26

-0.22

(-2.59%)

At close: 04:00PM EDT

8.26

0.00

(0.00%)

After hours:

04:01PM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	176.39M
Enterprise Value	76.45M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	3.42k
Price/Book (mrq)	1.05
Enterprise Value/Revenue	3.70k
Enterprise Value/EBITDA	0.10

Trading Information

Stock Price History

Beta (5Y Monthly)	1.03
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	29.70
52 Week Low ³	6.38
50-Day Moving Average ³	7.14
200-Day Moving Average ³	10.34

Share Statistics

Avg Vol (3 month) ³	212.84k
Avg Vol (10 day) ³	187.04k
Shares Outstanding ⁵	20.8M
Implied Shares Outstanding ⁶	N/A
Float ⁸	13.71M
% Held by Insiders ¹	1.23%
% Held by Institutions ¹	95.02%
Shares Short (Sep 30, 2024) ⁴	1.48M
Short Ratio (Sep 30, 2024) ⁴	9.71
Short % of Float (Sep 30, 2024) ⁴	7.17%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	7.12%
Shares Short (prior month Aug 30, 2024) ⁴	1.62M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-27.31%
Return on Equity (ttm)	-66.76%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	0.00
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-103.71M
Net Income Avi to Common (ttm)	-99.86M
Diluted EPS (ttm)	-7.89
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	173.83M
Total Cash Per Share (mrq)	8.36
Total Debt (mrq)	73.89M
Total Debt/Equity (mrq)	43.97
Current Ratio (mrq)	7.99
Book Value Per Share (mrq)	8.08

Cash Flow Statement

Operating Cash Flow (ttm)	-88.33M
Levered Free Cash Flow (ttm)	-54.43M